Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous.

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Innovative neuroblastoma research could lead to tailored treatments for high-risk patientsNew research has provided insight into the biological mechanisms that may contribute to poor outcomes in ...

Scientists have developed a revolutionary AI ‘fingerprint’ technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...

New study reveals how oesophageal cancer adapts to treatmentResearchers have tracked how the most common form of oesophageal cancer and its immune environment change during a standard form of ...

Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancerScientists have shown for the first time that some of the most persistent ...

In the largest and most comprehensive study of its kind, researchers have provided further evidence that a hormone responsible for regulating breast development acts as a risk factor for breast cancer ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The future of ovarian cancer: innovation, treatment and hopeOvarian cancer is the sixth most common cancer in the UK, with around 7,500 new cases annually, and globally more than 300,000 women are ...